Popular GLP-1 Weight-Loss Drugs Linked to 30% Lower Breast Cancer Risk
New research suggests GLP-1 medications may be associated with a lower likelihood of developing breast cancer.
Ozempic Is Finally Turning the Tide Against Obesity, New Data Shows
As the rate of GLP-1 prescriptions in the U.S. has risen, the obesity rate has dropped. (Lire plus...)